CHRISTIANAH OGUNLESI: Open Payments
NPI 1063507358 · BELLEROSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,042 in 123 payments from 13 companies in 2025. Trend: 2023 $1,511 · 2024 $1,971 · 2025 $3,042
Food & beverage: $3,042
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 16 | $608 |
| Neurocrine BioSciences, Inc. | 19 | $514 |
| Lundbeck LLC | 13 | $386 |
| Alkermes, Inc. | 17 | $377 |
| Teva Pharmaceuticals USA, Inc. | 30 | $324 |
| E.R. Squibb & Sons, L.L.C. | 6 | $278 |
| Otsuka America Pharmaceutical, Inc. | 12 | $257 |
| ABBVIE INC. | 4 | $117 |
| Janssen Scientific Affairs, LLC | 2 | $52 |
| Braeburn Inc. | 1 | $43 |
Products named: INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, UZEDY, COBENFY, ARISTADA, VIVITROL, VRAYLAR.
Industry payments across NY — which companies pay providers there.
